LAURUSLABSBSELAURUS LABS LIMITEDLowNeutral
Announced Tue, 13 Oct, 2026 · 16:55 IST

Laurus Labs Q2 and H1 FY27 Earnings Call set for October 29

Board & Shareholder Meetings View source PDFExplain this filing

LAURUSLABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.5%Reaction day
₹2060.00
prior close
₹2049.00
announcement price
After-mkt
timing
Nifty Midcap 150market-0.0%-1.5% vs market
Pharmaceuticals peers, median of 172sector+0.0%-1.5% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Midcap 150 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.1
15m
-0.5
30m
-0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.5-0.0-1.5+0.0-1.5
Next day
-2.0-0.3-1.7-0.8-1.2
2d
+0.0-0.4+0.4-0.6+0.6
3d
+0.4-1.5+1.9-1.9+2.3
4d
-2.3-2.9+0.6-3.5+1.2
5d
-2.8-3.7+0.9-4.4+1.6
1w
-0.1-4.7+4.6-4.4+4.3
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Laurus Labs will hold a conference call on October 29, 2026 at 5:00 PM IST to discuss its Q2 and H1 FY27 results, followed by a Q and A session. The call is hosted by DAM Capital Advisors. Dial-in details are provided for participants in India, Singapore, Hong Kong, USA, and UK. Investors and analysts can also join via Diamond Pass event link.

Likely market impact

No direct stock impact; investors should tune in for management commentary on quarterly performance and forward outlook.